1
|
Thompson LD: Osteosarcoma. Ear Nose Throat
J. 92:288–290. 2013.PubMed/NCBI
|
2
|
Liu X, Choy E, Hornicek FJ, Yang S, Yang
C, Harmon D, Mankin H and Duan Z: ROCK1 as a potential therapeutic
target in osteosarcoma. J Orthop Res. 29:1259–1266. 2011.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Ren XF, Mu LP, Jiang YS, Wang L and Ma JF:
LY2109761 inhibits metastasis and enhances chemosensitivity in
osteosarcoma MG-63 cells. Eur Rev Med Pharmacol Sci. 19:1182–1190.
2015.PubMed/NCBI
|
4
|
Yang Q, Zhang S, Kang M, Dong R and Zhao
J: Synergistic growth inhibition by sorafenib and cisplatin in
human osteosarcoma cells. Oncol Rep. 33:2537–2544. 2015.PubMed/NCBI
|
5
|
Zhang C, Hong CS, Hu X, Yang C, Wang H,
Zhu D, Moon S, Dmitriev P, Lu J, Chiang J, et al: Inhibition of
protein phosphatase 2A with the small molecule LB100 overcomes cell
cycle arrest in osteosarcoma after cisplatin treatment. Cell Cycle.
14:2100–2108. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Zhang R, Wang R, Chen Q and Chang H:
Inhibition of autophagy using 3-methyladenine increases
cisplatin-induced apoptosis by increasing endoplasmic reticulum
stress in U251 human glioma cells. Mol Med Rep. 12:1727–1732.
2015.PubMed/NCBI
|
7
|
Su Z, Yang Z, Xu Y, Chen Y and Yu Q:
MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget.
6:8474–8490. 2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Tang Y, Li M, Wang YL, Threadgill MD, Xiao
M, Mou CF, Song GL, Kuang J, Yang X, Yang L, et al: ART1 promotes
starvation-induced autophagy: A possible protective role in the
development of colon carcinoma. Am J Cancer Res. 5:498–513.
2015.PubMed/NCBI
|
9
|
Sun Y, Liu JH, Jin L, Sui YX, Han LL and
Huang Y: Effect of autophagy-related beclin1 on sensitivity of
Cisplatin-resistant ovarian cancer cells to chemotherapeutic
agents. Asian Pac J Cancer Prev. 16:2785–2791. 2015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Sun Y, Liu JH, Jin L, Sui YX, Lai L and
Yang Y: Inhibition of Beclin 1 expression enhances
cisplatin-induced apoptosis through a mitochondrial-dependent
pathway in human ovarian cancer SKOV3/DDP cells. Oncol Res.
21:261–269. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Zhang Z, Shao Z, Xiong L, Che B, Deng C
and Xu W: Expression of Beclin1 in osteosarcoma and the effects of
down-regulation of autophagy on the chemotherapeutic sensitivity.
29. 737–740. 2009.
|
12
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
13
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Zhou J, Liu R, Wang Y, Tang J, Tang S,
Chen X, Xia K, Xiong W, Xu D, Wang S, et al: miR-199a-5p regulates
the expression of metastasis-associated genes in B16F10 melanoma
cells. Int J Clin Exp Pathol. 7:7182–7190. 2014.PubMed/NCBI
|
15
|
Zhao X, He L, Li T, Lu Y, Miao Y, Liang S,
Guo H, Bai M, Xie H, Luo G, et al: SRF expedites metastasis and
modulates the epithelial to mesenchymal transition by regulating
miR-199a-5p expression in human gastric cancer. Cell Death Differ.
21:1900–1913. 2014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Hu Y, Liu J, Jiang B, Chen J, Fu Z, Bai F,
Jiang J and Tang Z: MiR-199a-5p loss up-regulated DDR1 aggravated
colorectal cancer by activating epithelial-to-mesenchymal
transition related signaling. Dig Dis Sci. 59:2163–2172. 2014.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Shin VY, Siu JM, Cheuk I, Ng EK and Kwong
A: Circulating cell-free miRNAs as biomarker for triple-negative
breast cancer. Br J Cancer. 112:1751–1759. 2015. View Article : Google Scholar : PubMed/NCBI
|
18
|
Wang F, Chan LW, Law HK, Cho WC, Tang P,
Yu J, Shyu CR, Wong SC, Yip SP and Yung BY: Exploring
microRNA-mediated alteration of EGFR signaling pathway in non-small
cell lung cancer using an mRNA: MiRNA regression model supported by
target prediction databases. Genomics. 104:504–511. 2014.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Yi H, Liang B, Jia J, Liang N, Xu H, Ju G,
Ma S and Liu X: Differential roles of miR-199a-5p in
radiation-induced autophagy in breast cancer cells. FEBS Lett.
587:436–443. 2013. View Article : Google Scholar : PubMed/NCBI
|
20
|
Xu N, Zhang J, Shen C, Luo Y, Xia L, Xue F
and Xia Q: Cisplatin-induced downregulation of miR-199a-5p
increases drug resistance by activating autophagy in HCC cell.
Biochem Biophys Res Commun. 423:826–831. 2012. View Article : Google Scholar : PubMed/NCBI
|
21
|
Kotsopoulos J, Zhang S, Akbari M, Salmena
L, Llacuachaqui M, Zeligs M, Sun P and Narod SA: BRCA1 mRNA levels
following a 4-6-week intervention with oral 3,3′-diindolylmethane.
Br J Cancer. 111:1269–1274. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Fang Y, Fang D and Hu J: MicroRNA and its
roles in esophageal cancer. Med Sci Monit. 18:RA22–RA30. 2012.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Rebecca VW and Amaravadi RK: Emerging
strategies to effectively target autophagy in cancer. Oncogene.
35:1–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
24
|
Pan B, Chen Y, Song H, Xu Y, Wang R and
Chen L: Mir-24-3p downregulation contributes to VP16-DDP resistance
in small-cell lung cancer by targeting ATG4A. Oncotarget.
6:317–331. 2015.PubMed/NCBI
|
25
|
Shen C, Wang W, Tao L, Liu B, Yang Z and
Tao H: Chloroquine blocks the autophagic process in
cisplatin-resistant osteosarcoma cells by regulating the expression
of p62/SQSTM1. Int J Mol Med. 32:448–456. 2013.PubMed/NCBI
|
26
|
He XJ, Ma YY, Yu S, Jiang XT, Lu YD, Tao
L, Wang HP, Hu ZM and Tao HQ: Up-regulated miR-199a-5p in gastric
cancer functions as an oncogene and targets klotho. BMC Cancer.
14:2182014. View Article : Google Scholar : PubMed/NCBI
|
27
|
Li Z, Song Y, Liu L, Hou N, An X, Zhan D,
Li Y, Zhou L, Li P, Yu L, et al: miR-199a impairs autophagy and
induces cardiac hypertrophy through mTOR activation. Cell Death
Differ. Jul 10–2015.(Epub ahead of print). View Article : Google Scholar
|
28
|
Lee JM, Heo MJ, Lee CG, Yang YM and Kim
SG: Increase of miR-199a-5p by protoporphyrin IX, a photocatalyzer,
directly inhibits E2F3, sensitizing mesenchymal tumor cells to
anti-cancer agents. Oncotarget. 6:3918–3931. 2015. View Article : Google Scholar : PubMed/NCBI
|
29
|
Zhu J, Chen X, Song Y, Zhang Y, Zhou L and
Wan L: Deficit of RACK1 contributes to the spatial memory
impairment via upregulating BECLIN1 to induce autophagy. Life Sci.
151:115–121. 2016. View Article : Google Scholar : PubMed/NCBI
|